Multidisciplinary Taiwan consensus for the use of conventional TACE in hepatocellular carcinoma treatment
Pi-Yi Chang(Taichung Veterans General Hospital), Huei‐Lung Liang(Kaohsiung Veterans General Hospital), Ming-Chih Chern(Koo Foundation Sun Yat-Sen Cancer Center), She‐Meng Cheng(Mackay Memorial Hospital), Hua-Ming Cheng(Chi Mei Medical Center), Po‐Chin Liang(National Taiwan University Hospital), Chia‐Ling Chiang(Kaohsiung Veterans General Hospital), Chih‐Horng Wu(National Taiwan University Hospital), Rheun‐Chuan Lee(Taipei Veterans General Hospital), Yi‐Sheng Liu(National Defense Medical Center), Reng‐Hong Wu(Chi Mei Medical Center), Yu‐Fan Cheng(Shanghai Medical College of Fudan University), Ding‐Kwo Wu(Kaohsiung Medical University), V. P. Chuang(The University of Texas System), Hsiuo‐Shan Tseng(Cheng Hsin General Hospital), Jen-I. Huang(Tungs' Taichung MetroHarbor Hospital), Chien‐Fu Hung(Johns Hopkins University)
Cited by 4
Related Papers
SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma
|Journal of Clinical Oncology|2018|653
Hepatogastroenterology
|Hepatogastroenterology|2012|536
Perspectives for therapeutic HPV vaccine development
|Journal of Biomedical Science|2016|231
Orantinib versus placebo combined with transcatheter arterial chemoembolisation in patients with unresectable hepatocellular carcinoma (ORIENTAL): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study
|The Lancet. Gastroenterology & hepatology|2017|200
Swallowing difficulty in Parkinson's disease
|Clinical Neurology and Neurosurgery|1997|170